New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Recent launches and approvals include the HeartWare ventricular assist system, Roche’s Elecsys HE4 assay for ovarian cancer and Coloplast’s Altis single-incision sling system.
You may also be interested in...
FDA Sticks Newly Approved HeartWare VAD With Unexpected Labeling Requirement
HeartWare International Inc.’s HeartWare Ventricular Assist System has finally gained PMA approval, but FDA labeling requirements have sparked questions from analysts.
FDA Panel Supports HeartWare VAD, Despite Trial Shortcomings
Benefits of HeartWare system, as well as the prospect of adding a competitive device to a market currently dominated by a single product, overshadow uncertainties from missing data, panelists vote.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.